Remarkably, FASN inhibition has minimal effect on non-malignant cells, because FASN has a low or absent expression in normal tissues but is overexpressed and hyperactivated in many carcinomas such as breast cancer [124]. This evidence concerns the gene FASN and breast carcinoma.